Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid vs Epinephrine for Bleeding Reduction in Upper GI Endoscopic Resection
NCT05688020Phase 4Recruiting
- Sponsor
- Shamir Medical Center
- Start
- Feb 2023
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in Gastric polyps, gastric cancer (GC), duodenal neoplasm, esophageal cancer, sponsored by Shamir Medical Center. Started Feb 2023; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
Gastric polypsgastric cancer (GC)duodenal neoplasmesophageal cancer
Beyond the preview
Go deeper on NCT05688020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05688020.